Prevention of schizophrenia deficits via non-invasive adolescent frontal cortex stimulation in rats

[1]  J. Pascau,et al.  Early neuromodulation prevents the development of brain and behavioral abnormalities in a rodent model of schizophrenia , 2018, Molecular Psychiatry.

[2]  A. Grace,et al.  Oxidative stress-driven parvalbumin interneuron impairment as a common mechanism in models of schizophrenia , 2017, Molecular Psychiatry.

[3]  C. Winter,et al.  Rats overexpressing the dopamine transporter display behavioral and neurobiological abnormalities with relevance to repetitive disorders , 2016, Scientific Reports.

[4]  A. Meyer-Lindenberg,et al.  Adverse Social Experiences in Adolescent Rats Result in Enduring Effects on Social Competence, Pain Sensitivity and Endocannabinoid Signaling , 2016, Front. Behav. Neurosci..

[5]  A. Vita,et al.  Schizophrenia , 2016, The Lancet.

[6]  Leigh E. Charvet,et al.  Safety of Transcranial Direct Current Stimulation: Evidence Based Update 2016 , 2016, Brain Stimulation.

[7]  J. Reis,et al.  Glia: A Neglected Player in Non-invasive Direct Current Brain Stimulation , 2016, Front. Cell. Neurosci..

[8]  M. Owen,et al.  Schizophrenia , 2016, The Lancet.

[9]  I. Weiner,et al.  Using a maternal immune stimulation model of schizophrenia to study behavioral and neurobiological alterations over the developmental course , 2015, Schizophrenia Research.

[10]  C. Winter,et al.  Medial Forebrain Bundle Deep Brain Stimulation has Symptom-specific Anti-depressant Effects in Rats and as Opposed to Ventromedial Prefrontal Cortex Stimulation Interacts With the Reward System , 2015, Brain Stimulation.

[11]  Marom Bikson,et al.  58 Trans-Spinal Direct Current Stimulation Immediately Modifies Motor Cortex Sensorimotor Maps , 2015, Brain Stimulation.

[12]  A. Der-Avakian,et al.  Anhedonia, avolition, and anticipatory deficits: Assessments in animals with relevance to the negative symptoms of schizophrenia , 2014, European Neuropsychopharmacology.

[13]  H. Kettenmann,et al.  Minocycline rescues decrease in neurogenesis, increase in microglia cytokines and deficits in sensorimotor gating in an animal model of schizophrenia , 2014, Brain, Behavior, and Immunity.

[14]  Ellis Rea,et al.  Anti-Anhedonic Effect of Deep Brain Stimulation of the Prefrontal Cortex and the Dopaminergic Reward System in a Genetic Rat Model of Depression: An Intracranial Self-Stimulation Paradigm Study , 2014, Brain Stimulation.

[15]  U. Meyer.  Prenatal Poly(I:C) Exposure and Other Developmental Immune Activation Models in Rodent Systems , 2014, Biological Psychiatry.

[16]  Thomas Götz,et al.  Mapping Brain Regions in Which Deep Brain Stimulation Affects Schizophrenia-Like Behavior in Two Rat Models of Schizophrenia , 2013, Brain Stimulation.

[17]  H. Möller,et al.  World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance , 2012, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[18]  I. Weiner,et al.  Effects of risperidone treatment in adolescence on hippocampal neurogenesis, parvalbumin expression, and vascularization following prenatal immune activation in rats , 2012, Brain, Behavior, and Immunity.

[19]  I. Weiner,et al.  Risperidone administered during asymptomatic period of adolescence prevents the emergence of brain structural pathology and behavioral abnormalities in an animal model of schizophrenia. , 2011, Schizophrenia bulletin.

[20]  I. Weiner,et al.  Abnormal Trajectories of Neurodevelopment and Behavior Following In Utero Insult in the Rat , 2011, Biological Psychiatry.

[21]  Heidi M. Schambra,et al.  Direct Current Stimulation Promotes BDNF-Dependent Synaptic Plasticity: Potential Implications for Motor Learning , 2010, Neuron.

[22]  A. Sawa,et al.  Review of pathological hallmarks of schizophrenia: comparison of genetic models with patients and nongenetic models. , 2010, Schizophrenia bulletin.

[23]  M. Buuse.  Modeling the Positive Symptoms of Schizophrenia in Genetically Modified Mice: Pharmacology and Methodology Aspects , 2010 .

[24]  Martin Bojar.  Department of Neurology , 2009 .

[25]  L. Cohen,et al.  Transcranial direct current stimulation: State of the art 2008 , 2008, Brain Stimulation.

[26]  N. Swerdlow,et al.  Realistic expectations of prepulse inhibition in translational models for schizophrenia research , 2008, Psychopharmacology.

[27]  Philip D. Harvey,et al.  Negative symptoms and cognitive deficits: what is the nature of their relationship? , 2006, Schizophrenia bulletin.

[28]  A. Addington,et al.  The neurodevelopmental model of schizophrenia: update 2005 , 2005, Molecular Psychiatry.

[29]  I. Weiner,et al.  Maternal immune activation leads to behavioral and pharmacological changes in the adult offspring. , 2005, Journal of psychiatric research.

[30]  J L Rapoport,et al.  The neurodevelopmental model of schizophrenia: update 2005 , 2005, Molecular Psychiatry.

[31]  M. Nitsche,et al.  Pharmacological Modulation of Cortical Excitability Shifts Induced by Transcranial Direct Current Stimulation in Humans , 2003, The Journal of physiology.

[32]  I. Weiner,et al.  Post-pubertal emergence of disrupted latent inhibition following prenatal immune activation , 2003, Psychopharmacology.

[33]  M. Nitsche,et al.  Sustained excitability elevations induced by transcranial DC motor cortex stimulation in humans , 2001, Neurology.

[34]  T. Insel,et al.  Preventing the onset of psychosis: not quite there yet. , 2015, Schizophrenia bulletin.

[35]  Marom Bikson,et al.  Modeling sequence and quasi-uniform assumption in computational neurostimulation. , 2015, Progress in brain research.

[36]  M. van den Buuse.  Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects. , 2010, Schizophrenia bulletin.

[37]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .